HB 1426

  • Indiana House Bill
  • 2025 Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Liability shield products.

Abstract

Defines a "liability shield product" as a certain type of product that has been designated as immune from liability under federal law. Requires a liability shield product to undergo a placebo controlled study before it is distributed, manufactured, marketed, or administered. Requires: (1) the Indiana department of health to monitor and publish certain information; and (2) certain entities to submit documentation and compliance reports; concerning liability shield products. Allows the attorney general or a private individual to bring an action if the requirements concerning liability shield products are not met.

Bill Sponsors (1)

Votes


No votes to display

Actions


Jan 13, 2025

House

Authored by Representative Borders

House

First reading: referred to Committee on Public Health

  • Reading-1
  • Referral-Committee
Public Health

Bill Text

Bill Text Versions Format
Introduced House Bill (H) PDF

Related Documents

Document Format
Fiscal Note: HB1426.01.INTR.FN002 PDF
Fiscal Note: HB1426.01.INTR.FN001 PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.